Advanced Respiratory Monitoring and Oxygen Therapy in Chronically Ill Patients With Acute Respiratory Failure

NANot yet recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 3, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

January 30, 2027

Conditions
Chronic Respiratory FailureCardiac Disease, Pulmonary DiseaseAcute Respiratory Failure (ARF)
Interventions
DEVICE

High-Flow Nasal Cannula (HFNC) Oxygen Therapy

"Type: Device / Procedure~Description: Humidified high-flow nasal cannula oxygen therapy delivered via a home device. Provides warmed (37°C), humidified air and supplemental oxygen at ≥30 L/min, titrated to maintain oxygen saturation (SpO₂) ≥92%. Patients are instructed to use the device for ≥8 hours per day, preferably overnight.~Special Features: Integrated remote monitoring system that automatically records flow, FiO₂, SpO₂, heart rate, and usage time, transmitting data to a secure cloud platform for clinical follow-up."

DEVICE

Oxygen therapy

"Type: Device / Procedure~Description: Standard long-term oxygen therapy delivered through conventional low-flow systems (e.g., nasal cannula or mask). Oxygen is titrated to maintain oxygen saturation (SpO₂) ≥92%. Patients are instructed to use oxygen for ≥8 hours per day, preferably overnight.~Special Features: No humidification, high-flow delivery, or remote monitoring capabilities."

All Listed Sponsors
collaborator

Arcispedale S. Anna, Ferrara

UNKNOWN

collaborator

University Hospital of Ferrara

OTHER

lead

Università degli Studi di Ferrara

OTHER

NCT07157696 - Advanced Respiratory Monitoring and Oxygen Therapy in Chronically Ill Patients With Acute Respiratory Failure | Biotech Hunter | Biotech Hunter